SkinnyRx
Compounded GLP-1 at the lowest monthly prices.
From
$69/mo
Consult
Free
Ships in
7d
M. в TX switched Ozempic → compounded semaglutide — $8,160/year
2 min ago · illustrative aggregate
Third-party reviews
Trustpilot
4.3/5
720 reviews
Aggregate snapshot, updated quarterly. Verify current scores on each platform.
Is SkinnyRx legit?
Short answer: yes — SkinnyRx is a legitimate compounded-GLP-1 telehealth provider (our editorial score: 5.5/10). Below are the legitimacy signals we verified, plus the honest caveats. GLP1Zoom earns a commission if you sign up via our link — but we don't sell anything ourselves и assess every provider the same way.
Licensed US telehealth
SkinnyRx operates as a licensed telehealth platform connecting patients to US-licensed prescribers.
Compounded medications (503A/503B)
SkinnyRx dispenses compounded GLP-1s — same active ingredient as brand, but compounded products are NOT FDA-approved as finished products. Legitimate model, но lower regulatory oversight than brand.
Established operating history
Founded 2023 — 3 years operating.
Transparent pricing
Publishes starting price ($69/mo) — no hidden-cost surprises at signup.
Still comparing? See SkinnyRx alternatives or our ranked best-GLP-1-telehealth list.
FDA Compliance Notice
SkinnyRx offers compounded GLP-1 medications. As of March 2026, the FDA has issued warning letters to multiple telehealth providers regarding compounded GLP-1 marketing. Discuss FDA-approved alternatives with your provider.
Learn more →Starting price
$69/mo
Consultation
Free
Insurance
No
Shipping
7d
About SkinnyRx
SkinnyRx markets compounded semaglutide and tirzepatide at very low prices. Received a March 2026 FDA warning letter — proceed with caution.
What we like
- +Lowest advertised monthly price ($69)
- +No consultation fee
Trade-offs
- −Received FDA warning letter in 2026 for compounded GLP-1 marketing
- −Operating in highest-risk regulatory category
- −Limited customer service hours
- −Aggressive marketing claims under scrutiny
Medications offered
Ozempic
compounded
$69/mo
Compounded Tirzepatide
compounded
$99–$299/mo
Compounded Semaglutide
compounded
$69–$199/mo
Considering a switch from SkinnyRx?
Compare alternative telehealth providers — pricing, drug menu, FDA-brand vs compounded.
People also ask about SkinnyRx
Is SkinnyRx legit?
Yes — SkinnyRx is a legitimate compounded-GLP-1 telehealth provider connecting patients to US-licensed prescribers, operating since 2023. Note: compounded medications are not FDA-approved as finished products — a legitimate but lower-oversight model.
Does SkinnyRx actually work for weight loss?
SkinnyRx prescribes GLP-1 medications (compounded semaglutide/tirzepatide) whose efficacy is well-established — semaglutide ~15% и tirzepatide ~22% average body-weight loss in trials. Results depend on the medication, dose adherence, и lifestyle, not the telehealth platform itself. SkinnyRx provides the prescription + delivery; the drug does the work.
How much does SkinnyRx cost?
SkinnyRx starts at $69/month. Final cost depends on medication, dose, и whether consultation/shipping are bundled. Verify current pricing on the SkinnyRx website.
Is SkinnyRx worth it?
SkinnyRx is worth considering if you want lower-cost compounded GLP-1s и are comfortable with the compounded model. Compare it against alternatives before deciding — see our SkinnyRx alternatives page.
How long does SkinnyRx take to ship?
SkinnyRx typically ships in about 7 days after prescription approval. GLP-1 medications arrive in insulated cold-chain packaging.
What are the best SkinnyRx alternatives?
Depending on your priority — lower cost, FDA-brand, female-focused care, or insurance support — several telehealth providers compete with SkinnyRx. See our SkinnyRx alternatives page for a ranked comparison.
30-second filter
What matters most to you?
Pick one. We'll line up the partners and FDA-approved options that match your priority. (Not medical screening — preference filter only.)
Why trust our experts
- Written by:
- John Doe, PharmD, BCACP
- Medically reviewed by:
- Jane Smith, MD, FACP
- Last reviewed:
- May 12, 2026